Owlet, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Owlet, Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding executive compensation, corporate governance, and director information.
NYSE
Owlet, Inc. filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NYSE
Owlet, Inc.'s 2024 10-K filing highlights record revenue, improved profitability, and strategic advancements in the pediatric health technology sector.
NYSE
Owlet, Inc. filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and security ownership.
NYSE
Owlet Inc.'s 10-K filing provides a detailed overview of its capital structure, including common and preferred stock, and outlines the regulatory environment it operates within, including FDA authorizations and international compliance.